[The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].
D000572:American Heart Association; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002309:Cardiology; D004357:Drug Synergism; D016099:Endoscopy, Gastrointestinal; D005762:Gastroenterology; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012306:Risk; D012955:Societies, Medical; D013392:Sucralfate / Q000627:therapeutic use; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D013392:Sucralfate